(LOAN) Manhattan Bridge Capital - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5628031065

LOAN: Mortgage Loans, Real Estate Financing

Manhattan Bridge Capital, Inc. is a real estate finance company specializing in the origination, servicing, and management of first mortgage loans secured by residential and commercial properties in the United States. The company provides short-term, secured, and non-banking loans to real estate investors for property acquisition, renovation, rehabilitation, or development. These loans are collateralized by real estate assets and typically include personal guarantees from the borrowers principals. As a real estate investment trust (REIT), the company is exempt from corporate income tax on the portion of its net income distributed to shareholders, enabling higher dividend payouts. Established in 1989 and headquartered in Great Neck, New York, Manhattan Bridge Capital operates with a focus on risk-adjusted returns and a disciplined approach to credit underwriting. The companys loan portfolio is primarily composed of short-duration, high-yield mortgages, allowing it to maintain liquidity and adapt to market conditions.

Over the next three months, LOAN is expected to maintain its stable performance, supported by consistent earnings from its loan portfolio. The stocks recent price of $5.58 aligns closely with its 20-day and 50-day moving averages, suggesting a balanced technical outlook. The 200-day moving average of $5.23 indicates potential for modest upward momentum. With an average true range (ATR) of 0.11, volatility is expected to remain low. Fundamentally, the companys market capitalization of $65.77M and a price-to-earnings (P/E) ratio of 11.73 reflect a moderate valuation. The return on equity (RoE) of 13.02% highlights profitability, though the price-to-sales (P/S) ratio of 8.90 suggests a need for revenue growth to justify current valuations. Overall, LOAN is anticipated to trade sideways with potential for slight appreciation, driven by its disciplined lending strategy and stable cash flows.

Additional Sources for LOAN Stock

LOAN Stock Overview

Market Cap in USD 63m
Sector Real Estate
Industry REIT - Mortgage
GiC Sub-Industry Mortgage REITs
IPO / Inception 1999-05-13

LOAN Stock Ratings

Growth 5y 62.6%
Fundamental 42.3%
Dividend 66.6%
Rel. Strength Industry 5.73
Analysts 3/5
Fair Price Momentum 6.13 USD
Fair Price DCF 0.79 USD

LOAN Dividends

Dividend Yield 12m 8.65%
Yield on Cost 5y 15.28%
Annual Growth 5y 1.84%
Payout Consistency 58.3%

LOAN Growth Ratios

Growth Correlation 3m 47.2%
Growth Correlation 12m 94.1%
Growth Correlation 5y 63.4%
CAGR 5y 12.89%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m -0.19
Alpha 20.06
Beta 0.24
Volatility 22.65%
Current Volume 11.3k
Average Volume 20d 8.9k
What is the price of LOAN stocks?
As of March 12, 2025, the stock is trading at USD 5.52 with a total of 11,343 shares traded.
Over the past week, the price has changed by -1.87%, over one month by -1.78%, over three months by +0.76% and over the past year by +25.65%.
Is Manhattan Bridge Capital a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Manhattan Bridge Capital (NASDAQ:LOAN) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.25 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LOAN as of March 2025 is 6.13. This means that LOAN is currently undervalued and has a potential upside of +11.05% (Margin of Safety).
Is LOAN a buy, sell or hold?
Manhattan Bridge Capital has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold LOAN.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for LOAN stock price target?
According to ValueRays Forecast Model, LOAN Manhattan Bridge Capital will be worth about 6.6 in March 2026. The stock is currently trading at 5.52. This means that the stock has a potential upside of +19.93%.
Issuer Forecast Upside
Wallstreet Target Price 7 26.8%
Analysts Target Price 7 26.8%
ValueRay Target Price 6.6 19.9%